Udi Meirav - Jul 26, 2021 Form 3 Insider Report for Candel Therapeutics, Inc. (CADL)

Role: Director
Signature: /s/ Udi Meirav
Stock symbol: CADL
Transactions as of: Jul 26, 2021
Transactions value $: $0
Form type: 3
Date filed: 7/26/2021, 09:25 PM

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CADL	Common Stock						48.8K	Jul 26, 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CADL	Stock Option (Right to Buy)							Jul 26, 2021	Common Stock	12.2K	$1.46	Direct	F1
holding	CADL	Stock Option (Right to Buy)							Jul 26, 2021	Common Stock	71.2K	$1.46	Direct	F2
holding	CADL	Stock Option (Right to Buy)							Jul 26, 2021	Common Stock	16.3K	$1.55	Direct	F2
holding	CADL	Stock Option (Right to Buy)							Jul 26, 2021	Common Stock	16.3K	$6.64	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of this option vested and became exercisable on January 1, 2019, with the remainder vesting in three substantially equal monthly installments thereafter.
F2	This option is fully vested and exercisable as of the date hereof.